Elon Musk's brain-implant company Neuralink on Thursday said the US Food and Drug Administration (FDA) had given the green light to its first-in-human clinical trial, a critical milestone after earlier struggles to gain approval.
from Gadgets 360 https://ift.tt/HoYF8iz
via IFTTT
from Gadgets 360 https://ift.tt/HoYF8iz
via IFTTT
Comments
Post a Comment